LO
Lobe Sciences Ltd.
LOBEF · OTC
$0.05 +0.00% (+$0.00)
1M -12.91%
Market Cap $20.1M
P/E Ratio -
Div. Yield -
ROE 338.76%
Bulios Fair Price
$0.06
20.2% upside
Current Price
$0.05
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LOBEF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 10.63x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 74.15%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 193.51%
ROE 338.76%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.18x
Current ratio 2.38x
Int. coverage -27.35x
Stability
29 /100
Unstable Beta 0.28x
EPS volatility 40.66%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LOBEF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Frederick Dominick Sancilio
Employees
0
Headquarters
Vancouver
Upcoming events
28 DEC
Earnings
Upcoming earnings report